<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">vavilov</journal-id><journal-title-group><journal-title xml:lang="ru">Вавиловский журнал генетики и селекции</journal-title><trans-title-group xml:lang="en"><trans-title>Vavilov Journal of Genetics and Breeding</trans-title></trans-title-group></journal-title-group><issn pub-type="epub">2500-3259</issn><publisher><publisher-name>Institute of Cytology and Genetics of Siberian Branch of the RAS</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.18699/vjgb-26-19</article-id><article-id custom-type="elpub" pub-id-type="custom">vavilov-5030</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>МОЛЕКУЛЯРНАЯ И КЛЕТОЧНАЯ БИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>MOLECULAR AND CELL BIOLOGY</subject></subj-group></article-categories><title-group><article-title>Наивные ИПСК человека, полученные при культивировании линии клеток ICGi022-A с праймированной плюрипотентностью в среде HENSM, способны к эффективной дифференцировке в эндотелиальные производные</article-title><trans-title-group xml:lang="en"><trans-title>Naïve human iPSCs obtained by culturing the ICGi022-A cell line with primed pluripotency in HENSM medium efficiently differentiate into endothelial derivatives</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Арссан</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Arssan</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><email xlink:type="simple">arsanmhdamin@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шевченко</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Shevchenko</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Закиян</surname><given-names>С. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakian</surname><given-names>S. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Захарова</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Zakharova</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Новосибирск</p></bio><bio xml:lang="en"><p>Novosibirsk</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">Федеральный исследовательский центр Институт цитологии и генетики Сибирского отделения Российской академии наук<country>Россия</country></aff><aff xml:lang="en">Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2026</year></pub-date><pub-date pub-type="epub"><day>06</day><month>04</month><year>2026</year></pub-date><volume>30</volume><issue>2</issue><fpage>181</fpage><lpage>193</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Арссан М.А., Шевченко А.И., Закиян С.М., Захарова И.С., 2026</copyright-statement><copyright-year>2026</copyright-year><copyright-holder xml:lang="ru">Арссан М.А., Шевченко А.И., Закиян С.М., Захарова И.С.</copyright-holder><copyright-holder xml:lang="en">Arssan M.A., Shevchenko A.I., Zakian S.M., Zakharova I.S.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://vavilov.elpub.ru/jour/article/view/5030">https://vavilov.elpub.ru/jour/article/view/5030</self-uri><abstract><p>Наивные плюрипотентные стволовые клетки (ПСК) человека – новый многообещающий инструмент биомедицинских исследований, открывающий доступ к ранним программам эмбрионального развития и прорывным решениям задач регенеративной медицины. Препятствием на пути к эффективному внедрению наивных ПСК в биомедицину является отсутствие возможности получать длительно культивируемые генетически и эпигенетически стабильные линии наивных ПСК. Ранее было заявлено, что культуральная среда HENSM позволяет индуцировать и длительно поддерживать линии наивных плюрипотентных стволовых клеток человека. В рамках данной работы мы проверили возможность получать стабильные линии наивных ПСК с использованием среды HENSM. С помощью среды HENSM мы успешно перевели линию ICGi022-A (K7-4Lf) праймированных индуцированных плюрипотентных стволовых клеток (ИПСК) здорового донора в наивное состояние. Наивные ИПСК растут в форме сфероподобных колоний как на питающем слое клеток, так и без него. Полученные клетки сохранили экспрессию ключевых факторов плюрипотентности и одновременно активировали транскрипционную программу наивных ПСК, включающую экспрессию эндогенных ретровирусных элементов, генов-маркеров раннего эпибласта и генов, ассоциированных с тотипотентностью. Наивная линия ИПСК была способна дифференцироваться в производные трех первичных зародышевых листков, а также давать производные трофобласта. При культивировании наивных ИПСК в низкоадгезивных условиях наблюдалось спонтанное формирование трехмерных структур – бластоидов, морфологически напоминающих ранние бластоцисты человека. Х-хромосома, имевшая нарушения в неактивном статусе в исходной линии клеток, реактивировалась в наивных клетках и восстанавливала нормальное неактивное состояние при повторном переводе наивных клеток в праймированное состояние. Важно отметить, что наивные ИПСК продемонстрировали низкую способность к прямой направленной дифференцировке в эндотелиоциты, однако их компетентность давать зрелые эндотелиальные производные восстанавливалась после их возврата к праймированному состоянию, достигая эффективности, сопоставимой с таковой у исходных праймированных ИПСК. Таким образом, полученная линия наивных ИПСК обладает значительным потенциалом для исследования ранних стадий эмбриогенеза и других биомедицинских приложений, включая моделирование заболеваний. Тем не менее при длительном культивировании с использованием среды HENSM наивная линия ICGi022-A оказалась кариотипически нестабильной. Поскольку риск кариотипических аберраций при поддержании наивных ПСК сохраняется, в дальнейшем для получения надежных, кариотипически стабильных линий наивных плюрипотентных клеток необходимо совершенствование условий культивирования.</p></abstract><trans-abstract xml:lang="en"><p>Naïve human pluripotent stem cells (PSCs) are a promising new tool in biomedical research. They provide access to the early embryonic development programmes and offer breakthrough solutions in regenerative medicine. However, the current inability to obtain long-term cultures of genetically and epigenetically stable naïve human PSC lines poses a challenge to their effective application in biomedicine. The recently proposed HENSM culture medium is claimed to enable the obtaining and long-term maintenance of naïve PSC lines. In this study, the potential of the HENSM medium for obtaining stable naïve human PSC lines was investigated. We successfully reset the primed induced pluripotent stem cell (iPSC) line ICGi022-A (K7-4Lf), derived from a healthy donor, to a naïve state using the HENSM medium. Naïve iPSCs grow in the form of dome-shaped colonies, both with and without a feeder layer of cells. The resulting cells retained expression of the key pluripotency factors and activated the naïve PSC transcriptional programme, including expression of endogenous retroviral elements, early epiblast marker genes and genes associated with totipotency. The naïve iPSC line was capable of differentiating into derivatives of the three primary germ layers, as well as producing trophoblast derivatives. Culturing naïve iPSCs in low-adhesion conditions resulted in the spontaneous formation of three-dimensional structures (blastoids) resembling early human blastocysts. The X chromosome, which was in an eroded inactive state in the original cell line, was reactivated in the naïve cells, but returned to its normal inactive state when the naïve cells were re-primed. Notably, naïve iPSCs demonstrated limited ability to directly differentiate into endothelial cells. However, their competence to give rise to mature endothelial derivatives was restored upon returning to the primed state, achieving comparable efficiency to the original primed iPSCs. Thus, the resulting naïve iPSC line has significant potential for studying the early stages of embryogenesis and for other biomedical applications, including disease modelling. However, the naïve ICGi022-A line proved to be karyotypically unstable during long-term cultivation using HENSM medium. As there is a risk of karyotypic aberrations during the maintenance of naïve PSCs, further improvement of the culture conditions is necessary to obtain reliable, karyotypically stable lines of naïve pluripotent cells.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>праймированные и наивные плюрипотентные стволовые клетки человека</kwd><kwd>направленная эндотелиальная дифференцировка</kwd><kwd>клеточные модели наследственных заболеваний</kwd></kwd-group><kwd-group xml:lang="en"><kwd>primed and naïve human pluripotent stem cells</kwd><kwd>directed endothelial differentiation</kwd><kwd>hereditary disease cellular models</kwd></kwd-group><funding-group xml:lang="en"><funding-statement>The immunefluorescent imaging was performed using resources of the Common Facilities Center of Microscopic Analysis of Biological Objects, ICG SB RAS (https://ckp.icgen.ru/ckpmabo/), supported by the State project of the Institute of Cytology and Genetics FWNR-2026–0024. M.A. Arssan is a member of Molecular Paleogenetics and Paleogenomics laboratory.</funding-statement></funding-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Alfeghaly C., Castel G., Cazottes E., Moscatelli M., Moinard E., Casanova M., Boni J., … Boers J., Gribnau J., David L., Ouimette J.F., Rougeulle C. XIST dampens X chromosome activity in a SPEN-dependent manner during early human development. Nat Struct Mol Biol. 2024;31(10):1589-1600. doi 10.1038/s41594-024-01325-3</mixed-citation><mixed-citation xml:lang="en">Alfeghaly C., Castel G., Cazottes E., Moscatelli M., Moinard E., Casanova M., Boni J., … Boers J., Gribnau J., David L., Ouimette J.F., Rougeulle C. XIST dampens X chromosome activity in a SPEN-dependent manner during early human development. Nat Struct Mol Biol. 2024;31(10):1589-1600. doi 10.1038/s41594-024-01325-3</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">An C., Feng G., Zhang J., Cao S., Wang Y., Wang N., Lu F., Zhou Q., Wang H. Overcoming autocrine FGF signaling-induced heterogeneity in naïve human ESCs enables modeling of random X chromosome inactivation. Cell Stem Cell. 2020;27(3):482-497. doi 10.1016/j.stem.2020.06.002</mixed-citation><mixed-citation xml:lang="en">An C., Feng G., Zhang J., Cao S., Wang Y., Wang N., Lu F., Zhou Q., Wang H. Overcoming autocrine FGF signaling-induced heterogeneity in naïve human ESCs enables modeling of random X chromosome inactivation. Cell Stem Cell. 2020;27(3):482-497. doi 10.1016/j.stem.2020.06.002</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Anguera M., Sadreyev R., Zhang Z., Szanto A., Payer B., Sheridan S., Kwok S., … Alvarez J., Gimelbrant A., Mitalipova M., Kirby J.E., Lee J.T. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell. 2012;11(1):75-90. doi 10.1016/j.stem.2012.03.008</mixed-citation><mixed-citation xml:lang="en">Anguera M., Sadreyev R., Zhang Z., Szanto A., Payer B., Sheridan S., Kwok S., … Alvarez J., Gimelbrant A., Mitalipova M., Kirby J.E., Lee J.T. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell. 2012;11(1):75-90. doi 10.1016/j.stem.2012.03.008</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Bayerl J., Ayyash M., Shani T., Manor Y., Gafni O., Massarwa R., Kalma Y., … Hanna S., Ben-Yosef D., Novershtern N., Viukov S., Hanna J.H. Principles of signaling pathway modulation for enhancing human naïve pluripotency induction. Cell Stem Cell. 2021;28(9): 1549-1565.e12. doi 10.1016/j.stem.2021.04.001</mixed-citation><mixed-citation xml:lang="en">Bayerl J., Ayyash M., Shani T., Manor Y., Gafni O., Massarwa R., Kalma Y., … Hanna S., Ben-Yosef D., Novershtern N., Viukov S., Hanna J.H. Principles of signaling pathway modulation for enhancing human naïve pluripotency induction. Cell Stem Cell. 2021;28(9): 1549-1565.e12. doi 10.1016/j.stem.2021.04.001</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Buckberry S., Liu X., Poppe D., Tan J.P., Sun G., Chen J., Nguyen T.V., … Breen J., Faulkner G.J., Nefzger C.M., Polo J.M., Lister R. Transient naïve reprogramming corrects hiPS cells functionally and epigenetically. Nature. 2023;620(7975):863-872. doi 10.1038/s41586-023-06424-7</mixed-citation><mixed-citation xml:lang="en">Buckberry S., Liu X., Poppe D., Tan J.P., Sun G., Chen J., Nguyen T.V., … Breen J., Faulkner G.J., Nefzger C.M., Polo J.M., Lister R. Transient naïve reprogramming corrects hiPS cells functionally and epigenetically. Nature. 2023;620(7975):863-872. doi 10.1038/s41586-023-06424-7</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Chan Y.S., Göke J., Ng J.H., Lu X., Gonzales K.A., Tan C.P., Tng W.Q., Hong Z.Z., Lim Y.S., Ng H.H. Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell. 2013;13(6):663-675. doi 10.1016/j.stem.2013.11.015</mixed-citation><mixed-citation xml:lang="en">Chan Y.S., Göke J., Ng J.H., Lu X., Gonzales K.A., Tan C.P., Tng W.Q., Hong Z.Z., Lim Y.S., Ng H.H. Induction of a human pluripotent state with distinct regulatory circuitry that resembles preimplantation epiblast. Cell Stem Cell. 2013;13(6):663-675. doi 10.1016/j.stem.2013.11.015</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Collier A., Rugg-Gunn P. Identifying human naïve pluripotent stem cells − evaluating state-specific reporter lines and cell-surface markers. BioEssays. 2018;40(5):1700239. doi 10.1002/bies.201700239</mixed-citation><mixed-citation xml:lang="en">Collier A., Rugg-Gunn P. Identifying human naïve pluripotent stem cells − evaluating state-specific reporter lines and cell-surface markers. BioEssays. 2018;40(5):1700239. doi 10.1002/bies.201700239</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">D’Antonio-Chronowska A., Donovan M.K.R., Young Greenwald W.W., Nguyen J.P., Fujita K., Hashem S., Matsui H., … Coulet F., Smith E.N., Adler E., D’Antonio M., Frazer K.A. Association of human iPSC gene signatures and X chromosome dosage with two distinct cardiac differentiation trajectories. Stem Cell Rep. 2019; 13(5):924-938. doi 10.1016/j.stemcr.2019.09.011</mixed-citation><mixed-citation xml:lang="en">D’Antonio-Chronowska A., Donovan M.K.R., Young Greenwald W.W., Nguyen J.P., Fujita K., Hashem S., Matsui H., … Coulet F., Smith E.N., Adler E., D’Antonio M., Frazer K.A. Association of human iPSC gene signatures and X chromosome dosage with two distinct cardiac differentiation trajectories. Stem Cell Rep. 2019; 13(5):924-938. doi 10.1016/j.stemcr.2019.09.011</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Dekel C., Morey R., Hanna J., Laurent L., Ben-Yosef D., Amir H. Stabilization of hESCs in two distinct substates along the continuum of pluripotency. iScience. 2022;25(12):105469. doi 10.1016/j.isci.2022.105469</mixed-citation><mixed-citation xml:lang="en">Dekel C., Morey R., Hanna J., Laurent L., Ben-Yosef D., Amir H. Stabilization of hESCs in two distinct substates along the continuum of pluripotency. iScience. 2022;25(12):105469. doi 10.1016/j.isci.2022.105469</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Di Giovannantonio L., Acampora D., Omodei D., Nigro V., Barba P., Barbieri E., Chambers I., Simeone A. Direct repression of Nanog and Oct4 by OTX2 modulates the contribution of epiblast-derived cells to germline and somatic lineage. Development. 2021;148(10): dev199166. doi 10.1242/dev.199166</mixed-citation><mixed-citation xml:lang="en">Di Giovannantonio L., Acampora D., Omodei D., Nigro V., Barba P., Barbieri E., Chambers I., Simeone A. Direct repression of Nanog and Oct4 by OTX2 modulates the contribution of epiblast-derived cells to germline and somatic lineage. Development. 2021;148(10): dev199166. doi 10.1242/dev.199166</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Disteche C.M. Dosage compensation of the sex chromosomes and autosomes. Semin Cell Dev Biol. 2016;56:9-18. doi 10.1016/j.semcdb.2016.04.013</mixed-citation><mixed-citation xml:lang="en">Disteche C.M. Dosage compensation of the sex chromosomes and autosomes. Semin Cell Dev Biol. 2016;56:9-18. doi 10.1016/j.semcdb.2016.04.013</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Duggal G., Warrier S., Ghimire S., Broekaert D., Van der Jeught M., Lierman S., Deroo T., … Heijmans B.T., Deforce D., De Sutter P., De Sousa Lopes S.C., Heindryckx B. Alternative routes to induce naïve pluripotency in human embryonic stem cells. Stem Cells. 2015;33(9):2686-2698. doi 10.1002/stem.2071</mixed-citation><mixed-citation xml:lang="en">Duggal G., Warrier S., Ghimire S., Broekaert D., Van der Jeught M., Lierman S., Deroo T., … Heijmans B.T., Deforce D., De Sutter P., De Sousa Lopes S.C., Heindryckx B. Alternative routes to induce naïve pluripotency in human embryonic stem cells. Stem Cells. 2015;33(9):2686-2698. doi 10.1002/stem.2071</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ee L.S., Medina-Cano D., Uyehara C.M., Schwarz C., Goetzler E., Salataj E., Polyzos A., Madhuranath S., Evans T., Hadjantonakis A.K., Apostolou E., Vierbuchen T., Stadtfeld M. Transcriptional remodeling by OTX2 directs specification and patterning of mammalian definitive endoderm. bioRxiv. 2024. doi 10.1101/2024.05.30.596630</mixed-citation><mixed-citation xml:lang="en">Ee L.S., Medina-Cano D., Uyehara C.M., Schwarz C., Goetzler E., Salataj E., Polyzos A., Madhuranath S., Evans T., Hadjantonakis A.K., Apostolou E., Vierbuchen T., Stadtfeld M. Transcriptional remodeling by OTX2 directs specification and patterning of mammalian definitive endoderm. bioRxiv. 2024. doi 10.1101/2024.05.30.596630</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Fischer L.A., Meyer B., Reyes M., Zemke J.E., Harrison J.K., Park K.M., Wang T., Jüppner H., Dietmann S., Theunissen T.W. Tracking and mitigating imprint erasure during induction of naïve human pluripotency at single-cell resolution. Stem Cell Rep. 2025;20(3):102419. doi 10.1016/j.stemcr.2025.102419</mixed-citation><mixed-citation xml:lang="en">Fischer L.A., Meyer B., Reyes M., Zemke J.E., Harrison J.K., Park K.M., Wang T., Jüppner H., Dietmann S., Theunissen T.W. Tracking and mitigating imprint erasure during induction of naïve human pluripotency at single-cell resolution. Stem Cell Rep. 2025;20(3):102419. doi 10.1016/j.stemcr.2025.102419</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Gafni O., Weinberger L., Mansour A.A., Manor Y.S., Chomsky E., Ben-Yosef D., Kalma Y., … Amann-Zalcenstein D., Benjamin S., Amit I., Tanay A., Massarwa R., Novershtern N., Hanna J.H. Derivation of novel human ground state naïve pluripotent stem cells. Nature. 2013; 504(7479):282-286. doi 10.1038/nature12745</mixed-citation><mixed-citation xml:lang="en">Gafni O., Weinberger L., Mansour A.A., Manor Y.S., Chomsky E., Ben-Yosef D., Kalma Y., … Amann-Zalcenstein D., Benjamin S., Amit I., Tanay A., Massarwa R., Novershtern N., Hanna J.H. Derivation of novel human ground state naïve pluripotent stem cells. Nature. 2013; 504(7479):282-286. doi 10.1038/nature12745</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Grigor’eva E.V., Kopytova A.E., Yarkova E.S., Pavlova S.V., Sorogina D.A., Malakhova A.A., Malankhanova T.B., Baydakova G.V., Zakharova E.Y., Medvedev S.P., Pchelina S.N., Zakian S.M. Biochemical characteristics of iPSC-derived dopaminergic neurons from N370S GBA variant carriers with and without Parkinson’s disease. Int J Mol Sci. 2023;24(5):4437. doi 10.3390/ijms24054437</mixed-citation><mixed-citation xml:lang="en">Grigor’eva E.V., Kopytova A.E., Yarkova E.S., Pavlova S.V., Sorogina D.A., Malakhova A.A., Malankhanova T.B., Baydakova G.V., Zakharova E.Y., Medvedev S.P., Pchelina S.N., Zakian S.M. Biochemical characteristics of iPSC-derived dopaminergic neurons from N370S GBA variant carriers with and without Parkinson’s disease. Int J Mol Sci. 2023;24(5):4437. doi 10.3390/ijms24054437</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Grigor’eva E.V., Karapetyan L.V., Malakhova A.A., Medvedev S.P., Minina J.M., Hayrapetyan V.H., Vardanyan V.S., Zakian S.M., Arakelyan A., Zakharyan R. Generation of iPSCs from a patient with the M694V mutation in the MEFV gene associated with Familial Mediterranean fever and their differentiation into macrophages. Int J Mol Sci. 2024;25(11):6102. doi 10.3390/ijms25116102</mixed-citation><mixed-citation xml:lang="en">Grigor’eva E.V., Karapetyan L.V., Malakhova A.A., Medvedev S.P., Minina J.M., Hayrapetyan V.H., Vardanyan V.S., Zakian S.M., Arakelyan A., Zakharyan R. Generation of iPSCs from a patient with the M694V mutation in the MEFV gene associated with Familial Mediterranean fever and their differentiation into macrophages. Int J Mol Sci. 2024;25(11):6102. doi 10.3390/ijms25116102</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Gu M. Efficient differentiation of human pluripotent stem cells to endothelial cells. Curr Protoc Hum Genet. 2018;98(1):e64. doi 10.1002/cphg.64</mixed-citation><mixed-citation xml:lang="en">Gu M. Efficient differentiation of human pluripotent stem cells to endothelial cells. Curr Protoc Hum Genet. 2018;98(1):e64. doi 10.1002/cphg.64</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Guo G., von Meyenn F., Rostovskaya M., Clarke J., Dietmann S., Baker D., Sahakyan A., Myers S., Bertone P., Reik W., Plath K., Smith A. Epigenetic resetting of human pluripotency. Development. 2017;144(15):2748-2763. doi 10.1242/dev.146811</mixed-citation><mixed-citation xml:lang="en">Guo G., von Meyenn F., Rostovskaya M., Clarke J., Dietmann S., Baker D., Sahakyan A., Myers S., Bertone P., Reik W., Plath K., Smith A. Epigenetic resetting of human pluripotency. Development. 2017;144(15):2748-2763. doi 10.1242/dev.146811</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Guo G., Stirparo G.G., Strawbridge S.E., Spindlow D., Yang J., Clarke J., Dattani A., Yanagida A., Li M.A., Myers S., Özel B.N., Nichols J., Smith A. Human naïve epiblast cells possess unrestricted lineage potential. Cell Stem Cell. 2021;28(6):1040-1056. doi 10.1016/j.stem.2021.02.025</mixed-citation><mixed-citation xml:lang="en">Guo G., Stirparo G.G., Strawbridge S.E., Spindlow D., Yang J., Clarke J., Dattani A., Yanagida A., Li M.A., Myers S., Özel B.N., Nichols J., Smith A. Human naïve epiblast cells possess unrestricted lineage potential. Cell Stem Cell. 2021;28(6):1040-1056. doi 10.1016/j.stem.2021.02.025</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Hossain I., Priam P., Reynoso S.C., Sahni S., Zhang X.X., Côté L., Doumat J., Chik C., Fu T., Lessard J.A., Pastor W.A. ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency. Nat Commun. 2024;15(1):8539. doi 10.1038/s41467-024-52431-1</mixed-citation><mixed-citation xml:lang="en">Hossain I., Priam P., Reynoso S.C., Sahni S., Zhang X.X., Côté L., Doumat J., Chik C., Fu T., Lessard J.A., Pastor W.A. ZIC2 and ZIC3 promote SWI/SNF recruitment to safeguard progression towards human primed pluripotency. Nat Commun. 2024;15(1):8539. doi 10.1038/s41467-024-52431-1</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Z., Li H., Jiang H., Ren Y., Yu X., Qiu J., Stablewski A., Zhang B., Buck M., Feng J. Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos. Sci Adv. 2020;6(20):eaaz0298. doi 10.1126/sciadv.aaz0298</mixed-citation><mixed-citation xml:lang="en">Hu Z., Li H., Jiang H., Ren Y., Yu X., Qiu J., Stablewski A., Zhang B., Buck M., Feng J. Transient inhibition of mTOR in human pluripotent stem cells enables robust formation of mouse-human chimeric embryos. Sci Adv. 2020;6(20):eaaz0298. doi 10.1126/sciadv.aaz0298</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Irie N., Surani M.A. Efficient induction and isolation of human primordial germ cell-like cells from competent human pluripotent stem cells. In: Buszczak M. (Ed.) Germline Stem Cells. Methods in Molecular Biology. Vol. 1463. Humana Press, New York, 2016;217-226. doi 10.1007/978-1-4939-4017-2_16</mixed-citation><mixed-citation xml:lang="en">Irie N., Surani M.A. Efficient induction and isolation of human primordial germ cell-like cells from competent human pluripotent stem cells. In: Buszczak M. (Ed.) Germline Stem Cells. Methods in Molecular Biology. Vol. 1463. Humana Press, New York, 2016;217-226. doi 10.1007/978-1-4939-4017-2_16</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">James D., Nam H.S., Seandel M., Nolan D., Janovitz T., Tomishima M., Studer L., Lee G., Lyden D., Benezra R., Zaninovic N., Rosenwaks Z., Rabbany S.Y., Rafii S. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhi-bition is Id1 dependent. Nat Biotechnol. 2010;28(2):161-166. doi 10.1038/nbt.1605</mixed-citation><mixed-citation xml:lang="en">James D., Nam H.S., Seandel M., Nolan D., Janovitz T., Tomishima M., Studer L., Lee G., Lyden D., Benezra R., Zaninovic N., Rosenwaks Z., Rabbany S.Y., Rafii S. Expansion and maintenance of human embryonic stem cell-derived endothelial cells by TGFβ inhi-bition is Id1 dependent. Nat Biotechnol. 2010;28(2):161-166. doi 10.1038/nbt.1605</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Khan S.A., Park K.M., Fischer L.A., Dong C., Lungjangwa T., Jimenez M., Casalena D., Chew B., Dietmann S., Auld D.S., Jaenisch R., Theunissen T.W. Probing the signaling requirements for naïve human pluripotency by high-throughput chemical screening. Cell Rep. 2021;35(11):109233. doi 10.1016/j.celrep.2021.109233</mixed-citation><mixed-citation xml:lang="en">Khan S.A., Park K.M., Fischer L.A., Dong C., Lungjangwa T., Jimenez M., Casalena D., Chew B., Dietmann S., Auld D.S., Jaenisch R., Theunissen T.W. Probing the signaling requirements for naïve human pluripotency by high-throughput chemical screening. Cell Rep. 2021;35(11):109233. doi 10.1016/j.celrep.2021.109233</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Kisa F., Shiozawa S., Oda K., Yoshimatsu S., Nakamura M., Koya I., Kawai K., Suzuki S., Okano H. Naïve-like ESRRB+ iPSCs with the capacity for rapid neural differentiation. Stem Cell Rep. 2017;9(6): 1825-1838. doi 10.1016/j.stemcr.2017.10.008</mixed-citation><mixed-citation xml:lang="en">Kisa F., Shiozawa S., Oda K., Yoshimatsu S., Nakamura M., Koya I., Kawai K., Suzuki S., Okano H. Naïve-like ESRRB+ iPSCs with the capacity for rapid neural differentiation. Stem Cell Rep. 2017;9(6): 1825-1838. doi 10.1016/j.stemcr.2017.10.008</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Klepikova A., Nenasheva T., Sheveleva O., Protasova E., Antonov D., Gainullina A., Chikina E., Sakovnich O., Gerasimova T., Nikitina I., Shevalie D., Lyadova I. iPSC-derived macrophages: the differentiation protocol affects cell immune characteristics and differentiation trajectories. Int J Mol Sci. 2022;23(24):16087. doi 10.3390/ijms232416087</mixed-citation><mixed-citation xml:lang="en">Klepikova A., Nenasheva T., Sheveleva O., Protasova E., Antonov D., Gainullina A., Chikina E., Sakovnich O., Gerasimova T., Nikitina I., Shevalie D., Lyadova I. iPSC-derived macrophages: the differentiation protocol affects cell immune characteristics and differentiation trajectories. Int J Mol Sci. 2022;23(24):16087. doi 10.3390/ijms232416087</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Kopytova A.E., Rychkov G.N., Cheblokov A.A., Grigor’eva E.V., Nikolaev M.A., Yarkova E.S., Sorogina D.A., … Bezrukikh V.A., Salogub G.N., Zakharova E.Y., Pchelina S.N., Emelyanov A.K. Potential binding sites of pharmacological chaperone NCGC00241607 on mutant β-glucocerebrosidase and its efficacy on patient-derived cell cultures in Gaucher and Parkinson’s disease. Int J Mol Sci. 2023;24(10):9105. doi 10.3390/ijms24109105</mixed-citation><mixed-citation xml:lang="en">Kopytova A.E., Rychkov G.N., Cheblokov A.A., Grigor’eva E.V., Nikolaev M.A., Yarkova E.S., Sorogina D.A., … Bezrukikh V.A., Salogub G.N., Zakharova E.Y., Pchelina S.N., Emelyanov A.K. Potential binding sites of pharmacological chaperone NCGC00241607 on mutant β-glucocerebrosidase and its efficacy on patient-derived cell cultures in Gaucher and Parkinson’s disease. Int J Mol Sci. 2023;24(10):9105. doi 10.3390/ijms24109105</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Lee J.H., Laronde S., Collins T.J., Shapovalova Z., Tanasijevic B., McNicol J.D., Fiebig-Comyn A., Benoit Y.D., Lee J.B., Mitchell R.R., Bhatia M. Lineage-specific differentiation is influenced by state of human pluripotency. Cell Rep. 2017;19(1):20-35. doi 10.1016/j.celrep.2017.03.036</mixed-citation><mixed-citation xml:lang="en">Lee J.H., Laronde S., Collins T.J., Shapovalova Z., Tanasijevic B., McNicol J.D., Fiebig-Comyn A., Benoit Y.D., Lee J.B., Mitchell R.R., Bhatia M. Lineage-specific differentiation is influenced by state of human pluripotency. Cell Rep. 2017;19(1):20-35. doi 10.1016/j.celrep.2017.03.036</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X., Nefzger C.M., Rossello F.J., Chen J., Knaupp A.S., Firas J., Ford E., … Nilsson S.K., Schittenhelm R.B., Laslett A.L., Lister R., Polo J.M. Comprehensive characterization of distinct states of human naïve pluripotency generated by reprogramming. Nat Methods. 2017;14(11):1055-1062. doi 10.1038/nmeth.4436</mixed-citation><mixed-citation xml:lang="en">Liu X., Nefzger C.M., Rossello F.J., Chen J., Knaupp A.S., Firas J., Ford E., … Nilsson S.K., Schittenhelm R.B., Laslett A.L., Lister R., Polo J.M. Comprehensive characterization of distinct states of human naïve pluripotency generated by reprogramming. Nat Methods. 2017;14(11):1055-1062. doi 10.1038/nmeth.4436</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Malakhova A.A., Grigor’eva E.V., Pavlova S.V., Malankhanova T.B., Valetdinova K.R., Vyatkin Y.V., Khabarova E.A., Rzaev J.A., Zakian S.M., Medvedev S.P. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population. Stem Cell Res. 2020;48:101952. doi 10.1016/j.scr.2020.101952</mixed-citation><mixed-citation xml:lang="en">Malakhova A.A., Grigor’eva E.V., Pavlova S.V., Malankhanova T.B., Valetdinova K.R., Vyatkin Y.V., Khabarova E.A., Rzaev J.A., Zakian S.M., Medvedev S.P. Generation of induced pluripotent stem cell lines ICGi021-A and ICGi022-A from peripheral blood mononuclear cells of two healthy individuals from Siberian population. Stem Cell Res. 2020;48:101952. doi 10.1016/j.scr.2020.101952</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Mathieu J., Detraux D., Kuppers D., Wang Y., Cavanaugh C., Sidhu S., Levy S., … Hawkins R.D., Moon R.T., Ware C.B., Paddison P.J., Ruohola-Baker H. Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency. Nat Commun. 2019;10(1):632. doi 10.1038/s41467-018-08020-0</mixed-citation><mixed-citation xml:lang="en">Mathieu J., Detraux D., Kuppers D., Wang Y., Cavanaugh C., Sidhu S., Levy S., … Hawkins R.D., Moon R.T., Ware C.B., Paddison P.J., Ruohola-Baker H. Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency. Nat Commun. 2019;10(1):632. doi 10.1038/s41467-018-08020-0</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Mazid M.A., Ward C., Luo Z., Liu C., Li Y., Lai Y., Wu L., … Maxwell P.H., Xu X., Liu L., Li W., Esteban M.A. Rolling back human pluripotent stem cells to an eight-cell embryo-like stage. Nature. 2022;605(7909):315-324. doi 10.1038/s41586-022-04625-0</mixed-citation><mixed-citation xml:lang="en">Mazid M.A., Ward C., Luo Z., Liu C., Li Y., Lai Y., Wu L., … Maxwell P.H., Xu X., Liu L., Li W., Esteban M.A. Rolling back human pluripotent stem cells to an eight-cell embryo-like stage. Nature. 2022;605(7909):315-324. doi 10.1038/s41586-022-04625-0</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Mekhoubad S., Bock C., De Boer A., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell. 2012;10(5):595-609. doi 10.1016/j.stem.2012.02.014</mixed-citation><mixed-citation xml:lang="en">Mekhoubad S., Bock C., De Boer A., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell. 2012;10(5):595-609. doi 10.1016/j.stem.2012.02.014</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Motosugi N., Sugiyama A., Okada C., Otomo A., Umezawa A., Akutsu H., Hadano S., Fukuda A. De-erosion of X chromosome dosage compensation by the editing of XIST regulatory regions restores the differentiation potential in hPSCs. Cell Rep Methods. 2022;2(12):100352. doi 10.1016/j.crmeth.2022.100352</mixed-citation><mixed-citation xml:lang="en">Motosugi N., Sugiyama A., Okada C., Otomo A., Umezawa A., Akutsu H., Hadano S., Fukuda A. De-erosion of X chromosome dosage compensation by the editing of XIST regulatory regions restores the differentiation potential in hPSCs. Cell Rep Methods. 2022;2(12):100352. doi 10.1016/j.crmeth.2022.100352</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Nadtochy J.A., Medvedev S.P., Grigor’eva E.V., Pavlova S.V., Minina J.M., Chechushkov A.V., Malakhova A.A., Kovalenko L.V., Zakian S.M. Transgenic iPSC lines with genetically encoded MitoTimer to study mitochondrial biogenesis in dopaminergic neurons with tauopathy. Biomedicines. 2025;13(3):550. doi 10.3390/biomedicines13030550</mixed-citation><mixed-citation xml:lang="en">Nadtochy J.A., Medvedev S.P., Grigor’eva E.V., Pavlova S.V., Minina J.M., Chechushkov A.V., Malakhova A.A., Kovalenko L.V., Zakian S.M. Transgenic iPSC lines with genetically encoded MitoTimer to study mitochondrial biogenesis in dopaminergic neurons with tauopathy. Biomedicines. 2025;13(3):550. doi 10.3390/biomedicines13030550</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Okae H., Toh H., Sato T., Hiura H., Takahashi S., Shirane K., Kabayama Y., Suyama M., Sasaki H., Arima T. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22(1):50-63. doi 10.1016/j.stem.2017.11.004</mixed-citation><mixed-citation xml:lang="en">Okae H., Toh H., Sato T., Hiura H., Takahashi S., Shirane K., Kabayama Y., Suyama M., Sasaki H., Arima T. Derivation of human trophoblast stem cells. Cell Stem Cell. 2018;22(1):50-63. doi 10.1016/j.stem.2017.11.004</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Ozaki H., Suga H., Sakakibara M., Soen M., Miyake N., Miwata T., Taga S., … Iguchi G., Takahashi Y., Muguruma K., Inoue H., Arima H. Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naïve state. Sci Rep. 2022;12(1): 17381. doi 10.1038/s41598-022-22405-8</mixed-citation><mixed-citation xml:lang="en">Ozaki H., Suga H., Sakakibara M., Soen M., Miyake N., Miwata T., Taga S., … Iguchi G., Takahashi Y., Muguruma K., Inoue H., Arima H. Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naïve state. Sci Rep. 2022;12(1): 17381. doi 10.1038/s41598-022-22405-8</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Patel S., Bonora G., Sahakyan A., Kim R., Chronis C., Langerman J., Fitz-Gibbon S., … Ardehali R., Pellegrini M., Lowry W.E., Clark A.T., Plath K. Human embryonic stem cells do not change their X inactivation status during differentiation. Cell Rep. 2017;18(1):54-67. doi 10.1016/j.celrep.2016.11.054</mixed-citation><mixed-citation xml:lang="en">Patel S., Bonora G., Sahakyan A., Kim R., Chronis C., Langerman J., Fitz-Gibbon S., … Ardehali R., Pellegrini M., Lowry W.E., Clark A.T., Plath K. Human embryonic stem cells do not change their X inactivation status during differentiation. Cell Rep. 2017;18(1):54-67. doi 10.1016/j.celrep.2016.11.054</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlova S.V., Shulgina A.E., Minina J.M., Zakian S.M., Dementyeva E.V. Generation of isogenic iPSC lines for studying the effect of the p.N515del (c.1543_1545delAAC) variant on MYBPC3 function and hypertrophic cardiomyopathy pathogenesis. Int J Mol Sci. 2024a;25(23):12900. doi 10.3390/ijms252312900</mixed-citation><mixed-citation xml:lang="en">Pavlova S.V., Shulgina A.E., Minina J.M., Zakian S.M., Dementyeva E.V. Generation of isogenic iPSC lines for studying the effect of the p.N515del (c.1543_1545delAAC) variant on MYBPC3 function and hypertrophic cardiomyopathy pathogenesis. Int J Mol Sci. 2024a;25(23):12900. doi 10.3390/ijms252312900</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Pavlova S.V., Shulgina A.E., Zakian S.M., Dementyeva E.V. Studying pathogenetic contribution of a variant of unknown significance, p.M659I (c.1977G &gt;A) in MYH7, to the development of hypertrophic cardiomyopathy using CRISPR/Cas9-engineered isogenic induced pluripotent stem cells. Int J Mol Sci. 2024b;25(16):8695. doi 10.3390/ijms25168695</mixed-citation><mixed-citation xml:lang="en">Pavlova S.V., Shulgina A.E., Zakian S.M., Dementyeva E.V. Studying pathogenetic contribution of a variant of unknown significance, p.M659I (c.1977G &gt;A) in MYH7, to the development of hypertrophic cardiomyopathy using CRISPR/Cas9-engineered isogenic induced pluripotent stem cells. Int J Mol Sci. 2024b;25(16):8695. doi 10.3390/ijms25168695</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Pham T.X.A., Panda A., Kagawa H., To S.K., Ertekin C., Georgolopoulos G., van Knippenberg S.S.F.A., … Lluis F., David L., Rivron N., Balaton B.P., Pasque V. Modeling human extraembryonic mesoderm cells using naïve pluripotent stem cells. Cell Stem Cell. 2022;29(9):1346-1365.e10. doi 10.1016/j.stem.2022.08.001</mixed-citation><mixed-citation xml:lang="en">Pham T.X.A., Panda A., Kagawa H., To S.K., Ertekin C., Georgolopoulos G., van Knippenberg S.S.F.A., … Lluis F., David L., Rivron N., Balaton B.P., Pasque V. Modeling human extraembryonic mesoderm cells using naïve pluripotent stem cells. Cell Stem Cell. 2022;29(9):1346-1365.e10. doi 10.1016/j.stem.2022.08.001</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Raposo A.C., Caldas P., Jeremias J., Arez M., Cazaux Mateus F., Barbosa P., Sousa-Luís R., … Mupo A., Eckersley-Maslin M., Casanova M., Grosso A.R., da Rocha S.T. Gene reactivation upon erosion of X chromosome inactivation in female hiPSCs is predictable yet variable and persists through differentiation. Stem Cell Rep. 2025;20(5):102472. doi 10.1016/j.stemcr.2025.102472</mixed-citation><mixed-citation xml:lang="en">Raposo A.C., Caldas P., Jeremias J., Arez M., Cazaux Mateus F., Barbosa P., Sousa-Luís R., … Mupo A., Eckersley-Maslin M., Casanova M., Grosso A.R., da Rocha S.T. Gene reactivation upon erosion of X chromosome inactivation in female hiPSCs is predictable yet variable and persists through differentiation. Stem Cell Rep. 2025;20(5):102472. doi 10.1016/j.stemcr.2025.102472</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Rezvova M.A., Ovcharenko E.A., Klyshnikov K.Y., Glushkova T.V., Kostyunin A.E., Shishkova D.K., Matveeva V.G., Velikanova E.A., Shabaev A.R., Kudryavtseva Y.A. Electrospun bioresorbable polymer membranes for coronary artery stents. Front Bioeng Biotechnol. 2024;12:1440181. doi 10.3389/fbioe.2024.1440181</mixed-citation><mixed-citation xml:lang="en">Rezvova M.A., Ovcharenko E.A., Klyshnikov K.Y., Glushkova T.V., Kostyunin A.E., Shishkova D.K., Matveeva V.G., Velikanova E.A., Shabaev A.R., Kudryavtseva Y.A. Electrospun bioresorbable polymer membranes for coronary artery stents. Front Bioeng Biotechnol. 2024;12:1440181. doi 10.3389/fbioe.2024.1440181</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Rostovskaya M. Capacitation of human naïve pluripotent stem cells. In: Rugg-Gunn P. (Ed.) Human Naïve Pluripotent Stem Cells. Methods in Molecular Biology. Vol. 2416. Humana, New York, 2022;117-131. doi 10.1007/978-1-0716-1908-7_9</mixed-citation><mixed-citation xml:lang="en">Rostovskaya M. Capacitation of human naïve pluripotent stem cells. In: Rugg-Gunn P. (Ed.) Human Naïve Pluripotent Stem Cells. Methods in Molecular Biology. Vol. 2416. Humana, New York, 2022;117-131. doi 10.1007/978-1-0716-1908-7_9</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Rostovskaya M., Stirparo G., Smith A. Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation. Development. 2019;146(7):dev172916. doi 10.1242/dev.172916</mixed-citation><mixed-citation xml:lang="en">Rostovskaya M., Stirparo G., Smith A. Capacitation of human naïve pluripotent stem cells for multi-lineage differentiation. Development. 2019;146(7):dev172916. doi 10.1242/dev.172916</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Sahakyan A., Kim R., Chronis C., Sabri S., Bonora G., Theunissen T., Kuoy E., Langerman J., Clark A., Jaenisch R., Plath K. Human naïve pluripotent stem cells model X chromosome dampening and X inactivation. Cell Stem Cell. 2017;20(1):87-101. doi 10.1016/j.stem.2016.10.006</mixed-citation><mixed-citation xml:lang="en">Sahakyan A., Kim R., Chronis C., Sabri S., Bonora G., Theunissen T., Kuoy E., Langerman J., Clark A., Jaenisch R., Plath K. Human naïve pluripotent stem cells model X chromosome dampening and X inactivation. Cell Stem Cell. 2017;20(1):87-101. doi 10.1016/j.stem.2016.10.006</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko A.I., Arssan A.M., Zakian S.M., Zakharova I.S. Chemokine CCL2 activates hypoxia response factors regulating pluripotency and directed endothelial differentiation of human pluripotent stem cells. Russ J Dev Biol. 2023;54(2):134-146. doi 10.1134/s1062360423020054</mixed-citation><mixed-citation xml:lang="en">Shevchenko A.I., Arssan A.M., Zakian S.M., Zakharova I.S. Chemokine CCL2 activates hypoxia response factors regulating pluripotency and directed endothelial differentiation of human pluripotent stem cells. Russ J Dev Biol. 2023;54(2):134-146. doi 10.1134/s1062360423020054</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Shevchenko A.I., Arssan A.M., Zakharova I.S. Towards the generation of safe naïve human pluripotent cell lines. Tomsk State Univ J Biol. 2025;69:184-193. doi 10.17223/19988591/69/21 (in Russian)</mixed-citation><mixed-citation xml:lang="en">Shevchenko A.I., Arssan A.M., Zakharova I.S. Towards the generation of safe naïve human pluripotent cell lines. Tomsk State Univ J Biol. 2025;69:184-193. doi 10.17223/19988591/69/21 (in Russian)</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Sheveleva O., Protasova E., Nenasheva T., Butorina N., Melnikova V., Gerasimova T., Sakovnich O., Kurinov A., Grigor’eva E., Medvedev S., Lyadova I. A model of iPSC-derived macrophages with TNFAIP3 overexpression reveals the peculiarities of TNFAIP3 protein expression and function in human macrophages. Int J Mol Sci 2023;24(16):12868. doi 10.3390/ijms241612868</mixed-citation><mixed-citation xml:lang="en">Sheveleva O., Protasova E., Nenasheva T., Butorina N., Melnikova V., Gerasimova T., Sakovnich O., Kurinov A., Grigor’eva E., Medvedev S., Lyadova I. A model of iPSC-derived macrophages with TNFAIP3 overexpression reveals the peculiarities of TNFAIP3 protein expression and function in human macrophages. Int J Mol Sci 2023;24(16):12868. doi 10.3390/ijms241612868</mixed-citation></citation-alternatives></ref><ref id="cit51"><label>51</label><citation-alternatives><mixed-citation xml:lang="ru">Sheveleva O., Protasova E., Grigor’eva E., Butorina N., Kuziaeva V., Antonov D., Melnikova V., Medvedev S., Lyadova I. The generation of genetically engineered human induced pluripotent stem cells overexpressing IFN-β for future experimental and clinically oriented studies. Int J Mol Sci. 2024;25(22):12456. doi 10.3390/ijms252212456</mixed-citation><mixed-citation xml:lang="en">Sheveleva O., Protasova E., Grigor’eva E., Butorina N., Kuziaeva V., Antonov D., Melnikova V., Medvedev S., Lyadova I. The generation of genetically engineered human induced pluripotent stem cells overexpressing IFN-β for future experimental and clinically oriented studies. Int J Mol Sci. 2024;25(22):12456. doi 10.3390/ijms252212456</mixed-citation></citation-alternatives></ref><ref id="cit52"><label>52</label><citation-alternatives><mixed-citation xml:lang="ru">Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010;24(20):2239-2263. doi 10.1101/gad.1963910</mixed-citation><mixed-citation xml:lang="en">Stadtfeld M., Hochedlinger K. Induced pluripotency: history, mechanisms, and applications. Genes Dev. 2010;24(20):2239-2263. doi 10.1101/gad.1963910</mixed-citation></citation-alternatives></ref><ref id="cit53"><label>53</label><citation-alternatives><mixed-citation xml:lang="ru">Szczerbinska I., Gonzales K.A.U., Cukuroglu E., Ramli M.N.B., Lee B.P.G., Tan C.P., Wong C.K., Rancati G.I., Liang H., Göke J., Ng H.H., Chan Y.S. A chemically defined feeder-free system for the establishment and maintenance of the human naïve pluripotent state. Stem Cell Rep. 2019;13(4):612-626. doi 10.1016/j.stemcr.2019.08.005</mixed-citation><mixed-citation xml:lang="en">Szczerbinska I., Gonzales K.A.U., Cukuroglu E., Ramli M.N.B., Lee B.P.G., Tan C.P., Wong C.K., Rancati G.I., Liang H., Göke J., Ng H.H., Chan Y.S. A chemically defined feeder-free system for the establishment and maintenance of the human naïve pluripotent state. Stem Cell Rep. 2019;13(4):612-626. doi 10.1016/j.stemcr.2019.08.005</mixed-citation></citation-alternatives></ref><ref id="cit54"><label>54</label><citation-alternatives><mixed-citation xml:lang="ru">Takashima Y., Guo G., Loos R., Nichols J., Ficz G., Krueger F., Oxley D., Santos F., Clarke J., Mansfield W., Reik W., Bertone P., Smith A. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell. 2014;158(6):1254-1269. doi 10.1016/j.cell.2014.08.029</mixed-citation><mixed-citation xml:lang="en">Takashima Y., Guo G., Loos R., Nichols J., Ficz G., Krueger F., Oxley D., Santos F., Clarke J., Mansfield W., Reik W., Bertone P., Smith A. Resetting transcription factor control circuitry toward ground-state pluripotency in human. Cell. 2014;158(6):1254-1269. doi 10.1016/j.cell.2014.08.029</mixed-citation></citation-alternatives></ref><ref id="cit55"><label>55</label><citation-alternatives><mixed-citation xml:lang="ru">Theunissen T.W., Powell B.E., Wang H., Mitalipova M., Faddah D.A., Reddy J., Fan Z.P., … Gao Q., Dawlaty M.M., Young R.A., Gray N.S., Jaenisch R. Systematic identification of culture conditions for induction and maintenance of naïve human pluripotency. Cell Stem Cell. 2014;15(4):471-487. doi 10.1016/j.stem.2014.07.002</mixed-citation><mixed-citation xml:lang="en">Theunissen T.W., Powell B.E., Wang H., Mitalipova M., Faddah D.A., Reddy J., Fan Z.P., … Gao Q., Dawlaty M.M., Young R.A., Gray N.S., Jaenisch R. Systematic identification of culture conditions for induction and maintenance of naïve human pluripotency. Cell Stem Cell. 2014;15(4):471-487. doi 10.1016/j.stem.2014.07.002</mixed-citation></citation-alternatives></ref><ref id="cit56"><label>56</label><citation-alternatives><mixed-citation xml:lang="ru">Theunissen T.W., Friedli M., He Y., Planet E., O’Neil R.C., Markoulaki S., Pontis J., … Drotar J., Lungjangwa T., Trono D., Ecker J.R., Jaenisch R. Molecular criteria for defining the naïve human pluripotent state. Cell Stem Cell. 2016;19(4):502-515. doi 10.1016/j.stem.2016.06.011</mixed-citation><mixed-citation xml:lang="en">Theunissen T.W., Friedli M., He Y., Planet E., O’Neil R.C., Markoulaki S., Pontis J., … Drotar J., Lungjangwa T., Trono D., Ecker J.R., Jaenisch R. Molecular criteria for defining the naïve human pluripotent state. Cell Stem Cell. 2016;19(4):502-515. doi 10.1016/j.stem.2016.06.011</mixed-citation></citation-alternatives></ref><ref id="cit57"><label>57</label><citation-alternatives><mixed-citation xml:lang="ru">Ustyantseva E., Pavlova S.V., Malakhova A.A., Ustyantsev K., Zakian S.M., Medvedev S.P. Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H2O2. Sci Rep. 2022;12(1):8928. doi 10.1038/s41598-022-12807-z</mixed-citation><mixed-citation xml:lang="en">Ustyantseva E., Pavlova S.V., Malakhova A.A., Ustyantsev K., Zakian S.M., Medvedev S.P. Oxidative stress monitoring in iPSC-derived motor neurons using genetically encoded biosensors of H2O2. Sci Rep. 2022;12(1):8928. doi 10.1038/s41598-022-12807-z</mixed-citation></citation-alternatives></ref><ref id="cit58"><label>58</label><citation-alternatives><mixed-citation xml:lang="ru">Valamehr B., Robinson M., Abujarour R., Rezner B., Vranceanu F., Le T., Medcalf A., Lee T., Fitch M., Robbins D., Flynn P. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep. 2014;2(3):366-381. doi 10.1016/j.stemcr.2014.01.014</mixed-citation><mixed-citation xml:lang="en">Valamehr B., Robinson M., Abujarour R., Rezner B., Vranceanu F., Le T., Medcalf A., Lee T., Fitch M., Robbins D., Flynn P. Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Rep. 2014;2(3):366-381. doi 10.1016/j.stemcr.2014.01.014</mixed-citation></citation-alternatives></ref><ref id="cit59"><label>59</label><citation-alternatives><mixed-citation xml:lang="ru">Vallot C., Ouimette J.F., Makhlouf M., Féraud O., Pontis J., Côme J., Martinat C., Bennaceur-Griscelli A., Lalande M., Rougeulle C. Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell. 2015;16(5):533-546. doi 10.1016/j.stem.2015.03.016</mixed-citation><mixed-citation xml:lang="en">Vallot C., Ouimette J.F., Makhlouf M., Féraud O., Pontis J., Côme J., Martinat C., Bennaceur-Griscelli A., Lalande M., Rougeulle C. Erosion of X chromosome inactivation in human pluripotent cells initiates with XACT coating and depends on a specific heterochromatin landscape. Cell Stem Cell. 2015;16(5):533-546. doi 10.1016/j.stem.2015.03.016</mixed-citation></citation-alternatives></ref><ref id="cit60"><label>60</label><citation-alternatives><mixed-citation xml:lang="ru">Vallot C., Patrat C., Collier A.J., Huret C., Casanova M., Liyakat Ali T.M., Tosolini M., Frydman N., Heard E., Rugg-Gunn P.J., Rougeulle C. XACT noncoding RNA competes with XIST in the control of X chromosome activity during human early development. Cell Stem Cell. 2017;20(1):102-111. doi 10.1016/j.stem.2016.10.014</mixed-citation><mixed-citation xml:lang="en">Vallot C., Patrat C., Collier A.J., Huret C., Casanova M., Liyakat Ali T.M., Tosolini M., Frydman N., Heard E., Rugg-Gunn P.J., Rougeulle C. XACT noncoding RNA competes with XIST in the control of X chromosome activity during human early development. Cell Stem Cell. 2017;20(1):102-111. doi 10.1016/j.stem.2016.10.014</mixed-citation></citation-alternatives></ref><ref id="cit61"><label>61</label><citation-alternatives><mixed-citation xml:lang="ru">Vaskova E.A., Medvedev S.P., Sorokina A.E., Nemudryy A.A., Elisaphenko E.A., Zakharova I.S., Shevchenko A.I., Kizilova E.A., Zhelezova A.I., Evshin I.S., Sharipov R.N. Transcriptome characteristics and X-chromosome inactivation status in cultured rat pluripotent stem cells. Stem Cells Dev. 2015;24(24):2912-2924. doi 10.1089/scd.2015.0204</mixed-citation><mixed-citation xml:lang="en">Vaskova E.A., Medvedev S.P., Sorokina A.E., Nemudryy A.A., Elisaphenko E.A., Zakharova I.S., Shevchenko A.I., Kizilova E.A., Zhelezova A.I., Evshin I.S., Sharipov R.N. Transcriptome characteristics and X-chromosome inactivation status in cultured rat pluripotent stem cells. Stem Cells Dev. 2015;24(24):2912-2924. doi 10.1089/scd.2015.0204</mixed-citation></citation-alternatives></ref><ref id="cit62"><label>62</label><citation-alternatives><mixed-citation xml:lang="ru">Ware C.B., Nelson A.M., Mecham B., Hesson J., Zhou W., Jonlin E.C., Jimenez-Caliani A.J., … Blau C.A., Treuting P.M., Hawkins R.D., Cirulli V., Ruohola-Baker H. Derivation of naïve human embryonic stem cells. Proc Natl Acad Sci USA. 2014;111(12):4484-4489. doi 10.1073/pnas.1319738111</mixed-citation><mixed-citation xml:lang="en">Ware C.B., Nelson A.M., Mecham B., Hesson J., Zhou W., Jonlin E.C., Jimenez-Caliani A.J., … Blau C.A., Treuting P.M., Hawkins R.D., Cirulli V., Ruohola-Baker H. Derivation of naïve human embryonic stem cells. Proc Natl Acad Sci USA. 2014;111(12):4484-4489. doi 10.1073/pnas.1319738111</mixed-citation></citation-alternatives></ref><ref id="cit63"><label>63</label><citation-alternatives><mixed-citation xml:lang="ru">Warr N., Powles-Glover N., Chappell A., Robson J., Norris D., Arkell R. Zic2-associated holoprosencephaly is caused by a transient defect in the organizer region during gastrulation. Hum Mol Gen. 2008;17(19):2986-2996. doi 10.1093/hmg/ddn197</mixed-citation><mixed-citation xml:lang="en">Warr N., Powles-Glover N., Chappell A., Robson J., Norris D., Arkell R. Zic2-associated holoprosencephaly is caused by a transient defect in the organizer region during gastrulation. Hum Mol Gen. 2008;17(19):2986-2996. doi 10.1093/hmg/ddn197</mixed-citation></citation-alternatives></ref><ref id="cit64"><label>64</label><citation-alternatives><mixed-citation xml:lang="ru">Welling M., Chen H.H., Muñoz J., Musheev M.U., Kester L., Junker J.P., Mischerikow N., Arbab M., Kuijk E., Silberstein L., Kharchenko P.V. DAZL regulates Tet1 translation in murine embryonic stem cells. EMBO Rep. 2015;16(7):791-802. doi 10.15252/embr.201540538</mixed-citation><mixed-citation xml:lang="en">Welling M., Chen H.H., Muñoz J., Musheev M.U., Kester L., Junker J.P., Mischerikow N., Arbab M., Kuijk E., Silberstein L., Kharchenko P.V. DAZL regulates Tet1 translation in murine embryonic stem cells. EMBO Rep. 2015;16(7):791-802. doi 10.15252/embr.201540538</mixed-citation></citation-alternatives></ref><ref id="cit65"><label>65</label><citation-alternatives><mixed-citation xml:lang="ru">Yarkova E.S., Grigor’eva E.V., Medvedev S.P., Tarasevich D.A., Pavlova S.V., Valetdinova K.R., Minina J.M., Zakian S.M., Malakhova A.A. Detection of ER stress in iPSC-derived neurons carrying the p. N370S mutation in the GBA1 gene. Biomedicines. 2024; 12(4):744. doi 10.3390/biomedicines12040744</mixed-citation><mixed-citation xml:lang="en">Yarkova E.S., Grigor’eva E.V., Medvedev S.P., Tarasevich D.A., Pavlova S.V., Valetdinova K.R., Minina J.M., Zakian S.M., Malakhova A.A. Detection of ER stress in iPSC-derived neurons carrying the p. N370S mutation in the GBA1 gene. Biomedicines. 2024; 12(4):744. doi 10.3390/biomedicines12040744</mixed-citation></citation-alternatives></ref><ref id="cit66"><label>66</label><citation-alternatives><mixed-citation xml:lang="ru">Yu L., Wei Y., Sun H.X., Mahdi A.K., Pinzon Arteaga C.A., Sakurai M., Schmitz D.A., … Okamura D., Mutto A.A., Gu Y., Ross P.J., Wu J. Derivation of intermediate pluripotent stem cells amenable to primordial germ cell specification. Cell Stem Cell. 2021;28(3):550-567. doi 10.1016/j.stem.2020.11.003</mixed-citation><mixed-citation xml:lang="en">Yu L., Wei Y., Sun H.X., Mahdi A.K., Pinzon Arteaga C.A., Sakurai M., Schmitz D.A., … Okamura D., Mutto A.A., Gu Y., Ross P.J., Wu J. Derivation of intermediate pluripotent stem cells amenable to primordial germ cell specification. Cell Stem Cell. 2021;28(3):550-567. doi 10.1016/j.stem.2020.11.003</mixed-citation></citation-alternatives></ref><ref id="cit67"><label>67</label><citation-alternatives><mixed-citation xml:lang="ru">Zakharova I.S., Zhiven’ M.K., Saaya S.B., Shevchenko A.I., Smirnova A.M., Strunov A., Karpenko A.A., Pokushalov E.A., Ivanova L.N., Makarevich P.I., Parfyonova Y.V. Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. J Transl Med. 2017;15(1):54. doi 10.1186/s12967-017-1156-1</mixed-citation><mixed-citation xml:lang="en">Zakharova I.S., Zhiven’ M.K., Saaya S.B., Shevchenko A.I., Smirnova A.M., Strunov A., Karpenko A.A., Pokushalov E.A., Ivanova L.N., Makarevich P.I., Parfyonova Y.V. Endothelial and smooth muscle cells derived from human cardiac explants demonstrate angiogenic potential and suitable for design of cell-containing vascular grafts. J Transl Med. 2017;15(1):54. doi 10.1186/s12967-017-1156-1</mixed-citation></citation-alternatives></ref><ref id="cit68"><label>68</label><citation-alternatives><mixed-citation xml:lang="ru">Zakharova I., Saaya S., Shevchenko A., Stupnikova A., Zhiven’ M., Laktionov P., Stepanova A., … Zavjalov E., Chernyavsky A., Romanov A., Karpenko A., Zakian S. Mitomycin-treated endothelial and smooth muscle cells suitable for safe tissue engineering approaches. Front Bioengin Biotechnol. 2022;10:772981. doi 10.3389/fbioe.2022.772981</mixed-citation><mixed-citation xml:lang="en">Zakharova I., Saaya S., Shevchenko A., Stupnikova A., Zhiven’ M., Laktionov P., Stepanova A., … Zavjalov E., Chernyavsky A., Romanov A., Karpenko A., Zakian S. Mitomycin-treated endothelial and smooth muscle cells suitable for safe tissue engineering approaches. Front Bioengin Biotechnol. 2022;10:772981. doi 10.3389/fbioe.2022.772981</mixed-citation></citation-alternatives></ref><ref id="cit69"><label>69</label><citation-alternatives><mixed-citation xml:lang="ru">Zakharova I.S., Shevchenko A.I., Arssan M.A., Sleptcov A.A., Nazarenko M.S., Zarubin A.A., Zheltysheva N.V., … Saaya S.B., Ezhov M.V., Kukharchuk V.V., Parfyonova Y.V., Zakian S.M. iPSCderived endothelial cells reveal LDLR dysfunction and dysregulated gene expression profiles in familial hypercholesterolemia. Int J Mol Sci. 2024;25(2):689. doi 10.3390/ijms25020689</mixed-citation><mixed-citation xml:lang="en">Zakharova I.S., Shevchenko A.I., Arssan M.A., Sleptcov A.A., Nazarenko M.S., Zarubin A.A., Zheltysheva N.V., … Saaya S.B., Ezhov M.V., Kukharchuk V.V., Parfyonova Y.V., Zakian S.M. iPSCderived endothelial cells reveal LDLR dysfunction and dysregulated gene expression profiles in familial hypercholesterolemia. Int J Mol Sci. 2024;25(2):689. doi 10.3390/ijms25020689</mixed-citation></citation-alternatives></ref><ref id="cit70"><label>70</label><citation-alternatives><mixed-citation xml:lang="ru">Zimmerlin L., Park T.S., Huo J.S., Verma K., Pather S.R., Talbot C.C., Jr., Agarwal J., … Cope L., Canto-Soler M.V., Friedman A.D., Baylin S.B., Zambidis E.T. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143(23):4368-4380. doi 10.1242/dev.138982</mixed-citation><mixed-citation xml:lang="en">Zimmerlin L., Park T.S., Huo J.S., Verma K., Pather S.R., Talbot C.C., Jr., Agarwal J., … Cope L., Canto-Soler M.V., Friedman A.D., Baylin S.B., Zambidis E.T. Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality. Development. 2016;143(23):4368-4380. doi 10.1242/dev.138982</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
